These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1358986)

  • 21. Patterns of opportunistic infections in patients with HIV infection.
    Finkelstein DM; Williams PL; Molenberghs G; Feinberg J; Powderly WG; Kahn J; Dolin R; Cotton D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):38-45. PubMed ID: 8624759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.
    Moore RD; Creagh-Kirk T; Keruly J; Link G; Wang MC; Richman D; Chaisson RE
    Arch Intern Med; 1991 May; 151(5):981-6. PubMed ID: 1673837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.
    Chakraborty A; Mahapatra T; Mahapatra S; Ansari S; Siddhanta S; Banerjee S; Banerjee D; Sarkar RN; Guha SK; Chakraborty N
    PLoS One; 2015; 10(2):e0117466. PubMed ID: 25679798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Digestive cytomegalovirus disease in AIDS patients].
    Barberá JR; Capdevila JA; García-Quintana AM; Calicó I; Allende H; Ruiz I; Ocaña I; Pahissa A
    Enferm Infecc Microbiol Clin; 1996; 14(7):411-5. PubMed ID: 8991434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
    Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
    Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus disease in AIDS: the Edinburgh experience.
    Cheong I; Flegg PJ; Brettle RP; Welsby PD; Burns SM; Dhillon B; Leen CL; Gray JA
    Int J STD AIDS; 1992; 3(5):324-8. PubMed ID: 1327173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
    N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
    Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.
    Gérard L; Leport C; Flandre P; Houhou N; Salmon-Céron D; Pépin JM; Mandet C; Brun-Vézinet F; Vildé JL
    Clin Infect Dis; 1997 May; 24(5):836-40. PubMed ID: 9142778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):780-6. PubMed ID: 17258320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
    Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Binquet C; Saillour F; Bernard N; Rougier MB; Leger F; Bonnal F; Dabis F
    Eur J Epidemiol; 2000 May; 16(5):425-32. PubMed ID: 10997829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of opportunistic disease on survival in patients with HIV infection.
    Chaisson RE; Gallant JE; Keruly JC; Moore RD
    AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.
    Yust I; Fox Z; Burke M; Johnson A; Turner D; Mocroft A; Katlama C; Ledergerber B; Reiss P; Kirk O;
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):550-9. PubMed ID: 15232720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
    Moore RD; Kessler H; Richman DD; Flexner C; Chaisson RE
    JAMA; 1991 May; 265(17):2208-11. PubMed ID: 2013953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD; Boom R; Wertheim-van Dillen PM; van den Horn GJ; Kijlstra A; de Smet MD
    Br J Ophthalmol; 1999 Oct; 83(10):1186-9. PubMed ID: 10502584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.